Comprehensive review of targeted therapy for colorectal cancer
YH Xie, YX Chen, JY Fang - Signal transduction and targeted therapy, 2020 - nature.com
Colorectal cancer (CRC) is among the most lethal and prevalent malignancies in the world
and was responsible for nearly 881,000 cancer-related deaths in 2018. Surgery and …
and was responsible for nearly 881,000 cancer-related deaths in 2018. Surgery and …
Cholangiocyte pathobiology
JM Banales, RC Huebert, T Karlsen… - Nature Reviews …, 2019 - nature.com
Cholangiocytes, the epithelial cells lining the intrahepatic and extrahepatic bile ducts, are
highly specialized cells residing in a complex anatomic niche where they participate in bile …
highly specialized cells residing in a complex anatomic niche where they participate in bile …
Receptor tyrosine kinase-targeted cancer therapy
T Yamaoka, S Kusumoto, K Ando, M Ohba… - International journal of …, 2018 - mdpi.com
In the past two decades, several molecular targeted inhibitors have been developed and
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …
evaluated clinically to improve the survival of patients with cancer. Molecular targeted …
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
PM Comoglio, L Trusolino, C Boccaccio - Nature Reviews Cancer, 2018 - nature.com
The MET oncogene encodes an unconventional receptor tyrosine kinase with pleiotropic
functions: it initiates and sustains neoplastic transformation when genetically altered …
functions: it initiates and sustains neoplastic transformation when genetically altered …
Wnt/β-catenin signaling in liver development, homeostasis, and pathobiology
JO Russell, SP Monga - Annual Review of Pathology …, 2018 - annualreviews.org
The liver is an organ that performs a multitude of functions, and its health is pertinent and
indispensable to survival. Thus, the cellular and molecular machinery driving hepatic …
indispensable to survival. Thus, the cellular and molecular machinery driving hepatic …
Building muscle: molecular regulation of myogenesis
CF Bentzinger, YX Wang… - Cold Spring Harbor …, 2012 - cshperspectives.cshlp.org
The genesis of skeletal muscle during embryonic development and postnatal life serves as a
paradigm for stem and progenitor cell maintenance, lineage specification, and terminal …
paradigm for stem and progenitor cell maintenance, lineage specification, and terminal …
Targeting MET in cancer: rationale and progress
E Gherardi, W Birchmeier, C Birchmeier… - Nature reviews …, 2012 - nature.com
Uncontrolled cell survival, growth, angiogenesis and metastasis are essential hallmarks of
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
cancer. Genetic and biochemical data have demonstrated that the growth and motility factor …
Orchestrating liver development
M Gordillo, T Evans, V Gouon-Evans - Development, 2015 - journals.biologists.com
The liver is a central regulator of metabolism, and liver failure thus constitutes a major health
burden. Understanding how this complex organ develops during embryogenesis will yield …
burden. Understanding how this complex organ develops during embryogenesis will yield …
An overview of the c-MET signaling pathway
SL Organ, MS Tsao - Therapeutic advances in medical …, 2011 - journals.sagepub.com
c-MET is a receptor tyrosine kinase that, after binding with its ligand, hepatocyte growth
factor, activates a wide range of different cellular signaling pathways, including those …
factor, activates a wide range of different cellular signaling pathways, including those …
MET signalling: principles and functions in development, organ regeneration and cancer
The MET tyrosine kinase receptor (also known as the HGF receptor) promotes tissue
remodelling, which underlies developmental morphogenesis, wound repair, organ …
remodelling, which underlies developmental morphogenesis, wound repair, organ …